Business Segments · Restructuring Reserve, Settled without Cash
Oncology & Multispecialty — Restructuring Reserve, Settled without Cash
Year-over-year, this metric declined by 100.0%, from $250.00K to $0.00.
Analysis
StatementSegment
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ2 2024
Last reportedQ1 2026
How to read this metric
High values indicate the company is preserving cash by using alternative settlement methods for restructuring obligations.
Detailed definition
Restructuring obligations that were satisfied through non-cash means, such as the issuance of equity, asset write-downs,...
Peer comparison
Specific disclosure found in the 'Restructuring' or 'Cash Flow' notes.
Metric ID:
mck_segment_oncology_multispecialty_restructuring_reserve_settled_without_cashHistorical Data
2 years
| FY'25 | FY'26 | |
|---|---|---|
| Value | $1.00M | $0.00 |
| YoY Change | — | -100.0% |
Range$0.00 – $1.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — restructuring reserve, settled without cash?
- McKesson (MCK) reported oncology & multispecialty — restructuring reserve, settled without cash of $0.00 in Q1 2026.
- How has McKesson's oncology & multispecialty — restructuring reserve, settled without cash changed year-over-year?
- McKesson's oncology & multispecialty — restructuring reserve, settled without cash decreased by 100.0% year-over-year, from $250.00K to $0.00.
- What does oncology & multispecialty — restructuring reserve, settled without cash mean?
- Restructuring costs paid using non-cash assets or equity.